A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
121
mentions
- X 44
- Bluesky 44
- Facebook 14
- News 10
- +3 more





